Lung Cancer Trial, Not Yet Recruiting NCT07170046 Sponsor: Guangdong Provincial People's Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07170046
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People whose CEA blood marker level was above 5 mg/l before surgery (CEA is a protein sometimes found at higher levels in people with certain cancers).
  • People who had a specific type of molecular blood test, called MRD testing, carried out before their surgery.
  • People whose main tumor was removed through surgery.
  • People who had at least two follow-up CEA blood tests and two follow-up MRD tests within 2 years after their surgery.
  • People whose tissue sample examined after surgery confirmed a malignant (cancerous) lung tumor.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose medical imaging records (such as scans) are not available.
  • People who have been diagnosed with another type of cancer at any point in the last five years.
  • People whose lung cancer has spread to the lungs from a cancer that started somewhere else in the body (sometimes called secondary or metastatic lung cancer).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Guangdong Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
15 September 2025
Est. completion
1 August 2027

Primary endpoints

Postoperative tumor recurrence or progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov